bpc-157 for neuropathy nerve inflammation autoimmune Conditions and Peptide Therapy BPC-157 & TB-500: What You
Description
Follow up after 12 years in both cases demonstrated partial recovery

Kolwicz, S

BPC157 showed linear pharmacokinetic characteristics in rats at the experimental dose

They work at different levels
